Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care

Journal of Korean Medical Science

Volumn 26, Issue 2, 2011, Pages 297-300

  Kim, Sunyong ^a   Ko, Kwan Soo ^b,c   Moon, Su Yeon ^a   Lee, Mi Suk ^a   Lee, Mi Young ^b   Son, Jun Seong ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Candida haemulonii; Candidemia; Caspofungin; Echinocandins

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE;

AGED; ARTICLE; CANDIDA; CANDIDIASIS; CASE REPORT; CATHETER INFECTION; CLASSIFICATION; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; LONG TERM CARE; MALE; MICROBIOLOGY; PATHOGENICITY; PHYLOGENY;

AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CATHETER-RELATED INFECTIONS; ECHINOCANDINS; FLUCONAZOLE; HOSPITALS; HUMANS; LONG-TERM CARE; MALE; PHYLOGENY;

EID: 79551665942     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.2.297     Document Type: Article

References (12)

1. Pfaller MA, Diekema DJ; International Fungal Surveillance Participant Group. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 2004; 10 Suppl 1: 11-23.
2. Vazquez JA, Lundstrom T, Dembry L, Chandrasekar P, Boikov D, Parri MB, Zervos MJ. Invasive Candida guilliermondii infection: in vitro susceptibility studies and molecular analysis. Bone Marrow Transplant 1995; 16: 849-53.
3. Gargeya IB, Pruitt WR, Meyer SA, Ahearn DG. Candida haemulonii from clinical specimens in the USA. J Med Vet Mycol 1991; 29: 335-8.
4. García-Martos P, Domínguez I, Marín P, García-Agudo R, Aoufi S, Mira J. Antifungal susceptibility of emerging yeast pathogens. Enferm Infecc Microbiol Clin 2001; 19: 249-56.
5. Khan ZU, Al-Sweih NA, Ahmad S, Al-Kazemi N, Khan S, Joseph L, Chandy R. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. J Clin Microbiol 2007; 45: 2025-7.
6. Ruan SY, Kuo YW, Huang CT, Hsiue HC, Hsueh PR. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes. Int J Antimicrob Agents 2010; 35: 85-8.
7. Van Uden N, Kolipinski MC. Torulopsis haemulonii nov. spec., a yeast from the Atlantic Ocean. Antonie Van Leeuwenhoek 1962; 28: 78-80.
8. Lavarde V, Daniel F, Saez H, Arnold M, Faguer B. Peritonite mycosique a Torulopsis haemulonii. Bull Soc Fr Mycol Med 1984; 13: 173-6.
9. Rodero L, Cuenca-Estrella M, Córdoba S, Cahn P, Davel G, Kaufman S, Guelfand L, Rodríguez-Tudela JL. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J Clin Microbiol 2002; 40: 2266-9.
10. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 2009; 48: e57-61.
11. Hong SK, Nam SH, Kim HC. Fatal peripheral candidal suppurative thrombophlebitis in a postoperative patient. J Korean Med Sci 2008; 23: 1094-6.
12. Han SS, Yim JJ, Yoo CG, Kim YW, Han SK, Shim YS, Lee SM. Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 years. J Korean Med Sci 2010; 25: 671-6.